Abesamis, Lilia D.
HRN: 01-19-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2023
CEFTAZIDIME 1GM (VIAL)
01/06/2023
01/12/2023
IVT
1g
Q8 ANST
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes